日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
28/04/2025 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | 刘殿波 | 1314(L) | +2,000,000(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | 刘殿波 | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | 刘殿波 | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
21/04/2025 | UBS Group AG | 1305(L) | 13,369,550(L) | 465,328,456(L) 464,873,640(S) | 12.37 12.36 | |
16/04/2025 | UBS Group AG | 1305(L) | 129,682,526(L) | 456,669,828(L) 463,472,105(S) | 12.14 12.32 | |
15/04/2025 | UBS Group AG | 1306(L) | 131,986,981(L) | 456,832,580(L) 463,053,391(S) | 12.14 12.31 | |
14/04/2025 | UBS Group AG | 1305(L) | 131,986,981(L) | 463,682,824(L) 469,465,634(S) | 12.33 12.48 | |
11/04/2025 | UBS Group AG | 1306(L) | 168,178,893(L) | 464,031,557(L) 469,480,810(S) | 12.34 12.48 | |
10/04/2025 | UBS Group AG | 1305(L) | 48,976,687(L) | 475,331,631(L) 469,563,967(S) | 12.64 12.48 | |
07/04/2025 | UBS Group AG | 1306(L) | 38,334,386(L) | 463,173,280(L) 466,873,915(S) | 12.31 12.41 | |
04/04/2025 | UBS Group AG | 1305(L) | 52,043,522(L) | 475,511,726(L) 472,610,255(S) | 12.64 12.56 | |
01/04/2025 | UBS Group AG | 1305(L) | 20,204,762(L) | 465,241,585(L) 464,973,721(S) | 12.37 12.36 | |
26/03/2025 | UBS Group AG | 1305(L) | 89,625,259(L) | 456,521,426(L) 462,106,251(S) | 12.14 12.28 | |
25/03/2025 | UBS Group AG | 1306(L) | 23,179,202(L) | 468,704,842(L) 473,773,176(S) | 12.46 12.59 | |
24/03/2025 | UBS Group AG | 1305(L) | 23,179,202(L) | 459,122,426(L) 462,929,167(S) | 12.21 12.31 | |
20/03/2025 | UBS Group AG | 1306(L) | 112,565,441(L) | 477,949,643(L) 478,926,424(S) | 12.71 12.73 | |
19/03/2025 | UBS Group AG | 1305(L) | 112,565,441(L) | 471,098,006(L) 469,405,376(S) | 12.52 12.48 | |
14/03/2025 | UBS Group AG | 1305(L) | 4,291,468(L) | 477,793,861(L) 478,334,837(S) | 12.70 12.72 | |
10/03/2025 | UBS Group AG | 1306(L) | 68,290,481(L) | 471,279,895(L) 470,580,221(S) | 12.53 12.51 | |
1 2 3 4 5 6 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 09/05/2025 18:00 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |